Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
QLS-31905 by Qilu Pharmaceutical for Pancreatic Cancer: Likelihood of Approval
QLS-31905 is under clinical development by Qilu Pharmaceutical and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Data Insights
QLS-31905 by Qilu Pharmaceutical for Gallbladder Cancer: Likelihood of Approval
QLS-31905 is under clinical development by Qilu Pharmaceutical and currently in Phase I for Gallbladder Cancer. According to GlobalData, Phase...